- Home
- GERN vs LFST Comparison
GERN vs LFST Comparison
Compare GERN & LFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- LFST
- Stock Information
- Founded
- GERN 1990
- LFST 2015
- Country
- GERN United States
- LFST United States
- Employees
- GERN N/A
- LFST N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- LFST Medical/Nursing Services
- Sector
- GERN Health Care
- LFST Health Care
- Exchange
- GERN Nasdaq
- LFST Nasdaq
- Market Cap
- GERN 2.5B
- LFST 2.9B
- IPO Year
- GERN 1996
- LFST 2021
- Fundamental
- Price
- GERN $2.89
- LFST $7.99
- Analyst Decision
- GERN Strong Buy
- LFST Buy
- Analyst Count
- GERN 10
- LFST 5
- Target Price
- GERN $7.15
- LFST $8.70
- AVG Volume (30 Days)
- GERN 14.8M
- LFST 1.2M
- Earning Date
- GERN 02-26-2025
- LFST 02-26-2025
- Dividend Yield
- GERN N/A
- LFST N/A
- EPS Growth
- GERN N/A
- LFST N/A
- EPS
- GERN N/A
- LFST N/A
- Revenue
- GERN $29,480,000.00
- LFST $1,206,093,000.00
- Revenue This Year
- GERN $31,478.06
- LFST $19.36
- Revenue Next Year
- GERN $290.89
- LFST $12.62
- P/E Ratio
- GERN N/A
- LFST N/A
- Revenue Growth
- GERN 9199.68
- LFST 20.08
- 52 Week Low
- GERN $1.64
- LFST $4.64
- 52 Week High
- GERN $5.34
- LFST $9.20
- Technical
- Relative Strength Index (RSI)
- GERN 25.84
- LFST 64.23
- Support Level
- GERN $2.80
- LFST $7.75
- Resistance Level
- GERN $3.68
- LFST $8.05
- Average True Range (ATR)
- GERN 0.18
- LFST 0.26
- MACD
- GERN -0.04
- LFST 0.04
- Stochastic Oscillator
- GERN 10.23
- LFST 87.06
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About LFST LifeStance Health Group Inc.
LifeStance Health Group Inc is a mental healthcare company focused on providing evidence-based, medically driven treatment services for children, adolescents, and adults suffering from a variety of mental health issues in an outpatient care setting, both in-person and through its digital health telemedicine offering.